DGK Inhibitor
-
DGKα-IN-7
0 ImagesCat. No.: HY-156577CAS No.: 2886092-50-6DGKα-IN-7 is a DGKα inhibitor with the IC50 of 6.225 nM, extracted from patent WO2022271684 (compound 100). DGKα-IN-7 has the potential for cancer study.
-
INCB191358
0 ImagesCat. No.: HY-183539CAS No.: 3111036-70-2INCB191358 is a selective and orally active inhibitor of diacylglycerol kinase α/ζ/ι (DGKα/ζ/ι ) with IC50 values of 0.12, 0.36 and 0.36 nM. INCB191358 induces antigen-dependent T-cell activation, induces IL-2 production and enhances antitumor efficacy in combination with PD-1 blockade. INCB191358 can be used for the research of cancer, such as colon carcinoma.
-
DGKζ-IN-6
0 ImagesCat. No.: HY-169317CAS No.: 3058005-75-4
-
Dioctanoylglycol (Standard)
0 ImagesSynonyms: Ethylene glycol dicaprylate (Standard); Ethylene glycol dioctanoate (Standard); Ethylenedioctanoate (Standard); (Standard)Dioctanoylglycol (Standard) is the analytical standard of Dioctanoylglycol (HY-100960). This product is intended for research and analytical applications. Dioctanoylglycol (Ethylene glycol dicaprylate), a diacylglycerol analog, is a diacylglycerol kinase (DGK) inhibitor (Ki of 58 μM).
